Analyst Ratings for Tabula Rasa Healthcare (TRHC)
TRHC Rating Summary
TRHC Price Target Summary
- Highest: $10.50 (Piper Sandler)
- Lowest: $7.00 (RBC Capital)
- Average: $9.17
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$9.17 (-12.7%)
* Over Last 12-Mos
Rating Score: 4.4 / 10
Percentile Rank: 44%
Avg. $ Target:
$9.17 (-12.7%)
* Over Last 12-Mos
Rating Score: 4.4 / 10
Percentile Rank: 44%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/7/2023 | Benchmark | Bill Sutherland | Downgrade | Hold (Buy) |
N/A (N/A) |
7.83 (10.50) |
34.1% | Details |
| 8/7/2023 | William Blair | Ryan Daniels | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
7.83 (10.50) |
34.1% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
